{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:32Z","timestamp":1786123352256,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Pain is one of the first presenting symptoms in patients with head and neck cancer, who often develop chronic and debilitating pain as the disease progresses. Pain is also an important prognostic marker for survival. Unfortunately, patients rarely receive effective pain treatment due to our limited knowledge of the mechanisms underlying head and neck cancer pain (HNCP). Pain is often associated with neuroinflammation and particularly interleukin (IL)-1 signaling. The purpose of this study is to develop a novel syngeneic model of HNCP in immunocompetent mice to examine the contribution of IL-1 signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Male C57BL\/6 mice were injected with a murine model of human papillomavirus (HPV+)\u2013induced oropharyngeal squamous cell carcinoma in their right hindlimb to induce tumor growth. Pain sensitivity was measured via von Frey filaments. Spontaneous pain was assessed via the facial grimace scale. IL-1\u03b2 was measured by quantifying gene expression via quantitative polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Pain hypersensitivity and spontaneous pain develop quickly after the implantation of tumor cells, a time when tumor volume is still insignificant. Spinal and circulating IL-1\u03b2 levels are significantly elevated in tumor-bearing mice. Blocking IL-1 signaling either by intrathecal administration of interleukin-1 receptor antagonist (IL-1ra) or by genetic deletion (interleukin-1 receptor knockout [\n                      <jats:italic toggle=\"yes\">Il1r1<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      ]) does not alleviate HNCP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>We established the first syngeneic model of HNCP in immunocompetent mice. Unlike inflammatory or nerve-injured pain, HNCP is independent of IL-1 signaling. These findings challenge the common belief that pain results from tissue compression or IL-1 signaling in patients with head and neck cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005302","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T16:20:42Z","timestamp":1607617242000},"page":"1156-1163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["A Novel Syngeneic Immunocompetent Mouse Model of Head and Neck Cancer Pain Independent of Interleukin-1 Signaling"],"prefix":"10.1213","volume":"132","author":[{"given":"Matthew J.","family":"Heussner","sequence":"first","affiliation":[{"name":"Department of Physiology and"},{"name":"College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Folger","sequence":"additional","affiliation":[{"name":"Department of Physiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Dias","sequence":"additional","affiliation":[{"name":"Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"Massri","sequence":"additional","affiliation":[{"name":"Department of Physiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Dahdah","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Molecular Genetics, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola D.","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Laumet","sequence":"additional","affiliation":[{"name":"Department of Physiology and"},{"name":"Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years.","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/00005537-200108000-00022","article-title":"A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data.","volume":"111","author":"Bjordal","year":"2001","journal-title":"Laryngoscope"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0011-8532(22)00090-8","article-title":"Cancer in the differential diagnosis of orofacial pain.","volume":"41","author":"Marshall","year":"1997","journal-title":"Dent Clin North Am"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tripleo.2010.11.033","article-title":"Pain may predict poor prognosis in patients with oral squamous cell carcinoma.","volume":"111","author":"Sato","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jpain.2014.07.003","article-title":"Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival.","volume":"15","author":"Reyes-Gibby","year":"2014","journal-title":"J Pain"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2004.09.002","article-title":"Evaluation of pain in patients with oral squamous cell carcinoma.","volume":"5","author":"Connelly","year":"2004","journal-title":"J Pain"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1097\/j.pain.0000000000001986","article-title":"Peripheral nerve injury and sensitization underlie pain associated with oral cancer perineural invasion.","volume":"161","author":"Salvo","year":"2020","journal-title":"Pain"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/NCC.0b013e3181d0b5ef","article-title":"Prevalence and correlates of supportive care needs in oral cancer patients with and without anxiety during the diagnostic period.","volume":"33","author":"Chen","year":"2010","journal-title":"Cancer Nurs"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/jpm.2010.0461","article-title":"Symptom patterns of patients with head and neck cancer in a palliative care unit.","volume":"14","author":"Lin","year":"2011","journal-title":"J Palliat Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer.","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1590\/1414-431X20143599","article-title":"Relationship of inflammatory markers and pain in patients with head and neck cancer prior to anticancer therapy.","volume":"47","author":"Oliveira","year":"2014","journal-title":"Braz J Med Biol Res"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia.","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1097\/j.pain.0000000000001044","article-title":"Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation.","volume":"158","author":"Scheff","year":"2017","journal-title":"Pain"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2018.07.016","article-title":"Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.","volume":"139","author":"Ye","year":"2018","journal-title":"Neuropharmacology"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnmol.2019.00216","article-title":"T cells as an emerging target for chronic pain therapy.","volume":"12","author":"Laumet","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"R16-20250502","first-page":"545","article-title":"Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma.","volume":"9","author":"Lei","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"e1356148","DOI":"10.1080\/2162402X.2017.1356148","article-title":"The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.","volume":"6","author":"de Ruiter","year":"2017","journal-title":"Oncoimmunology"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/s41467-018-06640-0","article-title":"Cancer exosomes induce tumor innervation.","volume":"9","author":"Madeo","year":"2018","journal-title":"Nat Commun"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hed.21040","article-title":"Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC.","volume":"31","author":"Williams","year":"2009","journal-title":"Head Neck"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2003.016014","article-title":"A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.","volume":"63","author":"Cohen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cellsig.2018.10.005","article-title":"Interleukin-1\u03b2 signaling in osteoarthritis - chondrocytes in focus.","volume":"53","author":"Jenei-Lanzl","year":"2019","journal-title":"Cell Signal"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbi.2017.07.008","article-title":"Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.","volume":"66","author":"Laumet","year":"2017","journal-title":"Brain Behav Immun"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"e20191430","DOI":"10.1084\/jem.20191430","article-title":"Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases.","volume":"217","author":"Mailhot","year":"2020","journal-title":"J Exp Med"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2017.02.006","article-title":"Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer.","volume":"79","author":"Vichaya","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw.","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of facial expressions of pain in the laboratory mouse.","volume":"7","author":"Langford","year":"2010","journal-title":"Nat Methods"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"100043","DOI":"10.1016\/j.ynpai.2020.100043","article-title":"CD3+ T cells are critical for the resolution of comorbid inflammatory pain and depression-like behavior.","volume":"7","author":"Laumet","year":"2020","journal-title":"Neurobiol Pain"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1097\/j.pain.0000000000001921","article-title":"Interleukin-10 resolves pain hypersensitivity induced by cisplatin by reversing sensory neuron hyperexcitability.","volume":"161","author":"Laumet","year":"2020","journal-title":"Pain"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.mex.2018.05.011","article-title":"Optimization of phenol-chloroform RNA extraction.","volume":"5","author":"Toni","year":"2018","journal-title":"MethodsX"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/0008-5472.CAN-17-2168","article-title":"Tumor-associated fatigue in cancer patients develops independently of IL1 signaling.","volume":"78","author":"Grossberg","year":"2018","journal-title":"Cancer Res"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/j.pain.0000000000001512","article-title":"Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice.","volume":"160","author":"Laumet","year":"2019","journal-title":"Pain"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41386-018-0075-z","article-title":"Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2,3 dioxygenase.","volume":"44","author":"Vichaya","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-016-0591-x","article-title":"Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice.","volume":"13","author":"Basso","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.4049\/jimmunol.1003335","article-title":"Endogenous opioid-mediated analgesia is dependent on adaptive T cell response in mice.","volume":"186","author":"Bou\u00e9","year":"2011","journal-title":"J Immunol"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/s41386-018-0154-1","article-title":"Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling.","volume":"43","author":"Laumet","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.11.010","article-title":"Metabolic hijacking: a survival strategy cancer cells exploit?","volume":"109","author":"Mitchell","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pain.2005.12.010","article-title":"Mitochondrial electron transport in models of neuropathic and inflammatory pain.","volume":"121","author":"Joseph","year":"2006","journal-title":"Pain"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/j.pain.0000000000000893","article-title":"HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.","volume":"158","author":"Krukowski","year":"2017","journal-title":"Pain"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-cellbio-101011-155833","article-title":"TRP channels and pain.","volume":"29","author":"Julius","year":"2013","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/carcin\/bgt312","article-title":"The neurotrophic factor neurturin contributes toward an aggressive cancer cell phenotype, neuropathic pain and neuronal plasticity in pancreatic cancer.","volume":"35","author":"Wang","year":"2014","journal-title":"Carcinogenesis"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:18Z","timestamp":1786112838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005302","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,3]]}}}